Shares of France's Accor went up 1.9 percent on Thursday following reports of a potential merger with UK's InterContinental Hotels that would form the world's biggest hotel group with a market value of about $17 billion.
A merger would result in a combined 1.6 million rooms, propelling them way ahead of US-based Marriott.
It could also make geographical sense, with Accor and its brands more skewed towards Europe, while IHG has larger operations in the United States and is also growing fast in Greater China.
According to the Le Figaro newspaper, no formal approach had been made by Accor, but Accor, its chairman and CEO Sebastien Bazin reportedly set up an internal task force to examine the possibility of a merger.
Le Figaro added that Accor's management board favored the deal, but Bazin was cautious about moving ahead.
Accor owns such brands such as Ibis and Movenpick, while IHG in the company behind the likes of Holiday Inn and Crowne Plaza.
Accor faces higher interest payments after being downgraded to junk status by S&P Global earlier this week that pulled its shares down over 43 percent so far.
Shares in IHG went down around 23 percent this year.
Both firms have announced cost-savings plans, including job cuts, to cope with the pandemic's effects.


Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
SK Hynix Shares Surge on Record $28.6 Billion Buyback
REPAY Stock Rises After Visa Platform Connect Collaboration
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



